openPR Logo
Press release

SMi Group announce Cell-Based Assays conference, 3rd & 4th October 2011

08-11-2011 07:56 AM CET | Health & Medicine

Press release from: SMi Group

SMi Group announce Cell-Based Assays conference, 3rd & 4th

SMi Group is delighted to announce their Cell-Based Assays conference, which will be held on the 21st and 22ndNovember 2011 in London.

Over the years, SMi has built a reputation as the leading producer of events relating to Cell-Based Assays in Europe. Now in its 4th year, the event has continued to evolve in response to the demands of our delegates and the pharmaceutical industry marketplace. The event will consist of a two day conference and two post-conference workshops, with a focus on a range of topics relating to the challenges facing those involved in using and developing cell-based assays and their importance to the strategic future of R&D in pharma.

Cell-Based Assays is the place for senior scientists from assay development, pharmacology, screening and related fields to meet and discuss progress in the area and exchange ideas moving forward. A dual focus on both strategic and regulatory concerns, alongside more specific scientific and technical analysis, supported with extensive case studies, ensures a truly comprehensive treatment of the most important issues.

Hear from our list of expert speakers who already include:
• Simon T. Barry, Oncology, AstraZeneca
• Firas Bassissi, Senior Scientist/Lab Manager, Preclinical Candidate Selection Unit, Abbott
• Nathan Bays, Research Fellow and Team Lead, High Throughput Flow Cytometry and Cell Biology, Merck & Co
• Davide Danovi, Research Associate, Cancer Unit, University College London
• Laura DeForge, Senior Scientist, Assay & Automation Technology, Genentech
• Alexandra Fuchs, COO, CYTOO Cell Architects
• Cedric Gaggioli, Research Fellow, INSERM
• Anker Jon Hansen, Principal Scientist, Novo Nordisk
• Daniel Kassel, Vice President, Takeda SD
• Stefan Kostense, Director, Clinical Assays, Crucell
• Steven Ludbrook, Cellular Section Head, GSK
• Katharina Maniura, Co-Head, Laboratory for Materials-Biology Interactions, EMPA
• Christian N. Parker, High Throughput Biology, NIBR, Novartis
• Corrine Ploix, Head of Assay Development and Qualification Immunosafety, Centre for Medical Genomics, Roche
• Stefan Przyborski, Director & CSO, Reinnervate and Professor of Cell Technology, University of Durham
• Peter Simpson, Associate Director, Assay Sciences Group, AstraZeneca
• Andrew Southan, Head, Ion Channel Pharmacology, Biofocus
• Glyn Stacey, Director of the UK Stem Cell Bank, NIBSC/HPA
• Pamela Tranter, Group Head, Automated Electrophysiology, Novartis
• Daniel Zicha, Head of Light Microscopy, Cancer Research UK

Why you should attend:
• Learn what new technologies and techniques are making the greatest impact in the area
• Navigate developments in 3D assaying technologies
• Explore the use of stem cells in discovery and development
• Discuss the future of this area and its importance to the sustainability of R&D in pharma
• Benefit from case studies from the world’s leading pharmaceutical companies
• Network with key industry associates and solution providers to share valuable experiences

Visit www.smi-online.co.uk/cell-based39.asp to register today! Alternatively, contact Zain Philbey at Tel: +44 (0) 20 7827 6722 or Email: zphilbey@smi-online.co.uk.
About SMi Group
Cell Based Assays is just one of the many conferences that are a part of the SMi Group portfolio.
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk/cell-based39.asp For further information, contact:
Zain Philbey
Tel: +44 0 207 827 6722
Email: zphilbey@smi-online.co.uk

About SMi Group
Cell Based Assays is just one of the many conferences that are a part of the SMi Group portfolio.
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk/pharma

Great Guildford Business Square, 30 Great Guildford Street, London, SE1 0HS

For more information on all of SMi's products & services please visit our website at www.smi-online.co.uk/pharma

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SMi Group announce Cell-Based Assays conference, 3rd & 4th October 2011 here

News-ID: 187130 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Cell

Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Load Cell Market Key Player Analysis By Single Point Load Cell, Compression Load …
The Load Cell Report consists of all the basic information regarding the Load Cell market. The all-inclusive report will aid users to understand the market current trends, industry growth drivers, share, analysis, size, production, forecast trends, supply, sales, demands, and many other aspects. The analysis was accomplished using an objective amalgamation of primary and secondary data including contributions from major participants in the market. The global Load Cell report is
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell …
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports. In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between
Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem …
Researchmoz added Most up-to-date research on "Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem Cell Culture, Neural Stem Cell Culture & Mesenchymal Stem Cell Culture" to its huge collection of research reports. In this report, the global Stem Cell Media market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a